724 related articles for article (PubMed ID: 33928029)
21. Magnetic Resonance Imaging-Based Radiomics Nomogram for Prediction of the Histopathological Grade of Soft Tissue Sarcomas: A Two-Center Study.
Yan R; Hao D; Li J; Liu J; Hou F; Chen H; Duan L; Huang C; Wang H; Yu T
J Magn Reson Imaging; 2021 Jun; 53(6):1683-1696. PubMed ID: 33604955
[TBL] [Abstract][Full Text] [Related]
22. Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram.
Guo Q; Lin Z; Lu J; Li R; Wu L; Deng L; Qiang J; Wu X; Gu Y; Li H
Abdom Radiol (NY); 2023 Mar; 48(3):1119-1130. PubMed ID: 36651979
[TBL] [Abstract][Full Text] [Related]
23. Radiomics signature from [
Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
[TBL] [Abstract][Full Text] [Related]
24. Machine Learning Model Based on Optimized Radiomics Feature from
Ni B; Huang G; Huang H; Wang T; Han X; Shen L; Chen Y; Hou J
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983281
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a [
Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of an
Huang J; Li T; Tang L; Hu Y; Hu Y; Gu Y
Acad Radiol; 2024 Jun; ():. PubMed ID: 38845294
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Radiomics Model Based on
Xue B; Jiang J; Chen L; Wu S; Zheng X; Zheng X; Tang K
Front Oncol; 2021; 11():740111. PubMed ID: 34765549
[TBL] [Abstract][Full Text] [Related]
28. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a nonenhanced CT based radiomics model to detect brown adipose tissue.
Li J; Zuo R; Schoepf UJ; Griffith JP; Wu S; Zhou C; Chen X; Tan W; Zhou Z; Gao H; Zhang L; Yang G
Theranostics; 2023; 13(5):1584-1593. PubMed ID: 37056567
[No Abstract] [Full Text] [Related]
30.
Mu W; Liang Y; Hall LO; Tan Y; Balagurunathan Y; Wenham R; Wu N; Tian J; Gillies RJ
Radiol Artif Intell; 2020 Nov; 2(6):e190218. PubMed ID: 33937845
[TBL] [Abstract][Full Text] [Related]
31. An Optimal Radiomics Nomogram Based on
Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
[TBL] [Abstract][Full Text] [Related]
32. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
[TBL] [Abstract][Full Text] [Related]
33. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
34. Value of
Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():567160. PubMed ID: 33262942
[TBL] [Abstract][Full Text] [Related]
35. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Radiomics Nomogram Based on
Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
Front Oncol; 2020; 10():1042. PubMed ID: 32766134
[No Abstract] [Full Text] [Related]
37. Development of a prediction model for gross residual in high-grade serous ovarian cancer by combining preoperative assessments of abdominal and pelvic metastases and multiparametric MRI.
Lu J; Cai S; Wang F; Wu PY; Pan X; Qiang J; Li H; Zeng M
Acad Radiol; 2023 Sep; 30(9):1823-1831. PubMed ID: 36587996
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a prognostic model incorporating [
Cheng NM; Hsieh CE; Fang YD; Liao CT; Ng SH; Wang HM; Chou WC; Lin CY; Yen TC
EJNMMI Res; 2020 Jul; 10(1):74. PubMed ID: 32632638
[TBL] [Abstract][Full Text] [Related]
39. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
40. CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancer.
Cao Y; Jiang Y; Song J; Zhang A; Duan S; Chen T; Wu F; Cheng W
Acta Radiol; 2023 Oct; 64(10):2802-2811. PubMed ID: 37553913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
